Medicine and Dentistry
Systematic Review
100%
Clinical Trial
85%
Skin Cancer
37%
Dermatology
31%
Cancer
27%
Diseases
27%
Skin Surgery
26%
Basal-Cell Carcinoma
25%
Mohs Surgery
23%
Dermatosis
22%
Rhinophyma
22%
Extramammary Paget's Disease
22%
Lymph Duct
22%
Sclerotherapy
22%
Randomized Controlled Trial
21%
Neck
21%
Biopsy Technique
19%
Patient Satisfaction
18%
Cosmetics
18%
Surgeon
18%
Skin Biopsy
17%
Quality of Life
15%
Vein Insufficiency
15%
Health Care Cost
14%
Medicine
14%
Health Care
14%
Neoplasm
14%
Chloasma
14%
Cancer Therapy
12%
Skin Carcinoma
12%
Combination Therapy
12%
Protein Expression
11%
Hypoxia
11%
Vascular Cell Adhesion Molecule 1
11%
Actinic Keratosis
11%
Biopsy
11%
Hypoxia Inducible Factor
11%
Sebaceous Carcinoma
11%
Suture Material
11%
Epidermal Growth Factor Receptor
11%
Mental Capacity
11%
Immunoglobulin A
11%
Cancer Registry
11%
Magnetic Resonance Imaging
11%
Endothelial Cell Line
11%
Hydralazine
11%
Acute Febrile Neutrophilic Dermatosis
11%
Botulinum Toxin
11%
Squamous Cell Carcinoma
11%
Tumor Necrosis Factor
11%
Keyphrases
Clinical Trials
93%
Core Outcome Set
91%
Systematic Literature Review
60%
Delphi Survey
52%
Delphi Method
29%
Consensus Conference
28%
Dermatologic Surgery
25%
Basal Cell Carcinoma
25%
Research-practice Gap
22%
Evidence-based Clinical Practice Guideline
22%
Skin Cancer Prevention
22%
Rosaceae
22%
Ultrasound-guided Foam Sclerotherapy
22%
Skin Cancer
21%
Laser Device
19%
Quality of Life
17%
Delphi Consensus
16%
Randomized Controlled Trial
16%
All Clinical Trials
16%
Medical Literature
13%
Cosmetic Surgery
13%
Treatment Evaluation
12%
Cutaneous Squamous Cell Carcinoma (cSCC)
12%
Reporting Quality
12%
Skin Biopsy
12%
Outcome Reporting
11%
Cutaneous Disease
11%
Mohs Micrographic Surgery
11%
Singles' Day
11%
Endothelial Cell Line
11%
Immunoglobulin
11%
Dermatologist
11%
Vascular Cell Adhesion molecule-1 (VCAM-1)
11%
Sebaceous Carcinoma
11%
Actinic Keratosis
11%
Past-present
11%
Futures Past
11%
Hypoxia-inducible Factor
11%
MHC Class I Gene
11%
MHC Class II Genes
11%
Suture Needle
11%
Squamous Cell Carcinoma (SqCC)
11%
Lymphatic Therapy
11%
Venous Medicine
11%
Patient Motivation
11%
Motivation
11%
Sweet Syndrome
11%
Tumor
11%
Non-invasive Fat Reduction
11%
Consensus Statement
11%